Css LLC Bellus Health Inc. Put Options Transaction History

Css LLC

  • $999 Million
  • Q3 2024

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$6.46 - $10.02 $130,492 - $202,404
20,200 Added 2885.71%
20,900 $193,000
Q4 2021

Feb 14, 2022
BUY
$5.26 - $8.3 $3,682 - $5,810
700 New
700 $6,000

Others Institutions Holding BLU

# of Institutions
1
Shares Held
128K
Call Options Held
0
Put Options Held
0
View Full List

About BELLUS Health Inc.

BLU Quotes by TradingView
  • Ticker BLU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,793,000
  • Description
  • BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...
More about BLU
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email